Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TMS in Primary Progressive Aphasia: Modulation of Brain Networks and Language

NCT04188067 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04188067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TMS in Primary Progressive Aphasia: Modulation of Brain Networks and Language
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2022
Completion date
August 25, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

logopenic variant primary progressive aphasia, non-fluent variant primary progressive aphasia, semantic variant primary progressive aphasia